Skip to main content
SpringerLink
Log in

Keine Rosazea durch Kalziumantagonisten?

Verdacht entkräftet

  • kurz & knapp
  • Published:
ästhetische dermatologie & kosmetologie Aims and scope

Kalziumantagonisten stehen im schlechten Ruf, wegen ihrer erythematogenen Eigenschaften die typischen Hauterscheinungen der Rosazea auszulösen. Offenbar zu Unrecht, wie eine Schweizer Studie gezeigt hat.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Spoendlin J et al. Br J Dermatol 2014 Jan 16

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Robert Bublak

Authors
  1. Robert Bublak
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bublak, R. Keine Rosazea durch Kalziumantagonisten?. ästhet dermatol kosmetol 6, 6 (2014). https://doi.org/10.1007/s12634-014-0878-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12634-014-0878-9

Search

Navigation